结核病:临床医生的最新情况
Saskia Janssen1,2, Melissa Murphy1, Caryn Upton1
1TASK, Cape Town, South Africa.
概括
结核病 (TB) 是一个主要的全球卫生问题,亚临床病例对其传播作出了重大贡献. 新的疫苗和治疗方法提供了希望,但药物耐药性和结核病后肺部疾病等挑战需要持续的研究和投资.
科学领域:
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 仍然是全球死亡的主要原因,目前为实现世界卫生组织 (WHO) 消除结核病目标的战略不足.
- 结核病的理解已经从明显的潜伏和活跃形式演变为复杂的疾病谱,其中亚临床感染在传播中发挥着关键作用.
研究的目的:
- 审查结核病控制的现状,强调最近的进展和诊断,预防和治疗的持续挑战.
- 强调需要继续研究和投资结核病疫苗,治疗药物和结核病后果的管理.
主要方法:
- 对结核病疫苗 (例如M72/AS01E) 和新型治疗方案的最新临床试验数据的审查.
- 对结核病传播的流行病学数据的分析,包括亚临床疾病和传染性的作用.
- 评估结核病预防治疗 (TPT) 实施的挑战以及对抗药性日益关注的问题.
主要成果:
- 亚临床结核病对传播有很大的贡献,即使是小结核病例也具有高度传染性.
- M72/AS01E疫苗显示有希望的初步结果,如果在更大的试验中得到证实,可能会影响结核病流行.
- 新的全口服,较短的治疗方案是一个突破,但受到贝达基林等药物耐药性增加的威胁.
- 结核病后肺部疾病 (PTLD) 是一个未被认可但影响幸存者的重要问题.
结论:
- 抗击结核病需要采取多方面的方法,包括开发有效的疫苗和新疗法来克服耐药性.
- 解决TPT实施的挑战,管理复杂的结核病例 (中枢神经系统结核病,艾滋病毒相关结核病) 和缓解PTLD至关重要.
- 持续投资结核病研究和控制战略对于制这一持续的全球健康威胁至关重要.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV
132
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
132
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis III
299
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
299
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K


